1999
DOI: 10.1021/jf981330u
|View full text |Cite
|
Sign up to set email alerts
|

Cyclodextrin-Based Optosensor for the Determination of Warfarin in Waters

Abstract: A flow-through optosensor for warfarin is described. The sensor is developed in conjunction with flow analysis systems and uses a commercial bound beta-cyclodextrin material as the sensing phase. A strong fluorescence signal was observed as a result of the formation of an inclusion complex between warfarin and beta-cyclodextrin. The analytical performance characteristics of the proposed sensor for analysis of low levels of warfarin were as follows: the detection limits for continuous and flow injection analysi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2005
2005
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(9 citation statements)
references
References 26 publications
0
8
0
1
Order By: Relevance
“…A flow-through optosensor for warfarin is described [97]. The sensor is developed in conjunction with flow analysis systems and uses a commercial bound β-cyclodextrin material as the sensing phase.…”
Section: Fluorescencementioning
confidence: 99%
“…A flow-through optosensor for warfarin is described [97]. The sensor is developed in conjunction with flow analysis systems and uses a commercial bound β-cyclodextrin material as the sensing phase.…”
Section: Fluorescencementioning
confidence: 99%
“…[13][14][15] Driven by hydrophobic interactions, small molecules, including warfarin, tend to bind to b-cyclodextrin (b-CD), which has a Correspondence concerning this article should be addressed to V. I. Vullev at vullev@ucr.edu. Scheme 2).…”
Section: Introductionmentioning
confidence: 99%
“…Such studies would become especially interesting once structures of vitamin K epoxide reductase become available. At the same time, the formation of inclusion complexes of warfarin with b-cyclodextrin is of technological importance, both in the context of chiral separations [44,45] and biosensing applications [46,47], but details of the molecular interactions between warfarin and b-cyclodextrin remain largely unknown.…”
Section: Discussionmentioning
confidence: 99%